During the past decade, Cleveland Clinic taussig Cancer Center Investigational Pharmacy conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic taussig Cancer Center Investigational Pharmacy" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Clinic taussig Cancer Center Investigational Pharmacy" are "Advanced Solid Tumors" (1 trials), "Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors" (1 trials), "Epithelial Ovarian Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Cleveland Clinic taussig Cancer Center Investigational Pharmacy" in a lesser frequency.

Most popular intervention types in "Cleveland Clinic taussig Cancer Center Investigational Pharmacy" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "5-FU" (1 trials), "Avelumab Phase 1b" (1 trials), "Avelumab Phase 2" (1 trials), "Bevacizumab" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Clinic taussig Cancer Center Investigational Pharmacy" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cleveland Clinic taussig Cancer Center Investigational Pharmacy". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cleveland Clinic taussig Cancer Center Investigational Pharmacy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Clinic taussig Cancer Center Investigational Pharmacy, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".